Inter Pharma PCL
SET:IP
IP's latest stock split occurred on May 7, 2024
The company executed a 13-for-8 stock split, meaning that for every 8 shares held, investors received 13 new shares.
Before the split, IP traded at 9.6 per share. Afterward, the share price was about 6.7.
The adjusted shares began trading on May 7, 2024. This was IP's 3rd stock split, following the previous one in Jul 20, 2021.
Global
Stock Splits Monitor
Inter Pharma PCL
Glance View
Inter Pharma PCL is engaged in biopharmaceutical business. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2019-11-05. The firm is principally engaged in the importing, manufacturing and distribution of dietary supplement product for humans and animals. The firm provides wellness and anti-aging products, aesthetic innovation products, animal health products and livestock products. Its wellness and anti-aging products include Probac7, Probac10 plus, TS6, Beta Glucan Plus, Pure Krill Oil, Astacurmin and YUUU Cleansing Mousse. Its aesthetic innovation products include Perfectha Complement, Perfectha Derm, Perfectha Deep and Perfectha Subskin. The Company’s animal health products include Dr.Choice Cal-B, Dr.Choice Cardi-B, Petinol, Pet Select Senior, Pet Select Osteoflex and Malaseb Shampoo for dogs and cats. The company also offers pet foods for dogs and cats. Its subsidiaries include Inter Vetta Co., Ltd., Modern Pharma Co., Ltd. and Inter Petrina Co., Ltd.
2650
MPG
1949
CSLLY